Jonathan Waldstreicher, MD

Jonathan Waldstreicher, MD, is the Founder and CEO of Galvanize Therapeutics, Inc., a biomedical company specializing in innovative therapies using Pulsed Electric Field (PEF) technology. He has been leading Galvanize since its inception in March 2022 and is based in Redwood City, California. The company focuses on developing medical devices aimed at treating various conditions, particularly in interventional oncology and pulmonology, with a notable product for chronic bronchitis currently undergoing clinical trials.124

Professional Background

Dr. Waldstreicher has a rich background in the medical device and pharmaceutical sectors, accumulating over 25 years of experience. Before founding Galvanize, he held several significant roles:

• Partner at Apple Tree Partners since May 2013.
• Founder and CEO of Galaxy Medical from March 2020 to March 2022.
• He also established Gala Therapeutics and served as its CEO from October 2015 to March 2022.23

His earlier career included positions at Johnson & Johnson, where he worked as Director of Emerging Technologies, and he completed a surgery internship at Tufts Medical Center. His educational background includes a dual MD/MBA from Tufts University School of Medicine, along with a BA in Economics from Brandeis University.23

Current Focus

Under Dr. Waldstreicher's leadership, Galvanize Therapeutics aims to expand its market presence, having already established its technologies in approximately 70 US hospitals and treated around 3,000 patients through clinical trials and commercial applications. The company is also actively working on new product developments and expanding clinical indications for its existing technologies.145

Dr. Waldstreicher's vision emphasizes the importance of innovative solutions in treating complex medical conditions, aiming to improve patient outcomes through advanced therapeutic technologies.14